Amag Pharmaceuticals to buy stem cell bank for $700 mln

June 29 (Reuters) - Amag Pharmaceuticals Inc said it would buy privately held stem cell bank Cord Blood Registry for $700 million to strengthen is maternal health business.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.